Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Chung Cheng

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 4, 2022
Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch StudyFeng-Yu Kuo, Cheng-Han Lee, Wei-Ren Lan, et al.
Cardiovascular Intervention and Therapeutics|May 22, 2021
Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacyPing-Yen Liu, Cheng-Huang Su, Feng-Yu Kuo, et al.
Acta Cardiologica Sinica|November 28, 2022
A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch StudyWen-Lieng Lee, Yi-Chih Wang, Chieh-Shou Su, et al.
Cardiovascular Intervention and Therapeutics|April 4, 2021
Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacyPing-Yen Liu, Cheng-Huang Su, Feng-Yu Kuo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 4, 2022
Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch StudyFeng-Yu Kuo, Cheng-Han Lee, Wei-Ren Lan, et al.
Cardiovascular Intervention and Therapeutics|May 22, 2021
Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacyPing-Yen Liu, Cheng-Huang Su, Feng-Yu Kuo, et al.
Acta Cardiologica Sinica|November 28, 2022
A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch StudyWen-Lieng Lee, Yi-Chih Wang, Chieh-Shou Su, et al.
Cardiovascular Intervention and Therapeutics|April 4, 2021
Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacyPing-Yen Liu, Cheng-Huang Su, Feng-Yu Kuo, et al.
Pageof 2